Nathan M. Nutter

Array ( [id] => 2823683 [patent_doc_number] => 05173505 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-12-22 [patent_title] => 'Anti-neoplastic, anti-viral and ribonucleotide reductase activity affecting pharmaceutical compositions and methods of treatment' [patent_app_type] => 1 [patent_app_number] => 7/645644 [patent_app_country] => US [patent_app_date] => 1991-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3651 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/173/05173505.pdf [firstpage_image] =>[orig_patent_app_number] => 645644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2714952 [patent_doc_number] => 05053453 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1991-10-01 [patent_title] => 'Thromboresistant materials and methods for making same' [patent_app_type] => 1 [patent_app_number] => 7/641320 [patent_app_country] => US [patent_app_date] => 1991-01-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 3 [patent_no_of_words] => 5623 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/053/05053453.pdf [firstpage_image] =>[orig_patent_app_number] => 641320 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2931882 [patent_doc_number] => 05260056 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-11-09 [patent_title] => 'Composition for enhancing biosynthesis of interferon' [patent_app_type] => 1 [patent_app_number] => 7/640750 [patent_app_country] => US [patent_app_date] => 1991-01-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3171 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 89 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/260/05260056.pdf [firstpage_image] =>[orig_patent_app_number] => 640750 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3036064 [patent_doc_number] => 05300564 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-04-05 [patent_title] => 'Doped sol-gel glasses for obtaining chemical interactions' [patent_app_type] => 1 [patent_app_number] => 7/637873 [patent_app_country] => US [patent_app_date] => 1991-01-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 5267 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 157 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/300/05300564.pdf [firstpage_image] =>[orig_patent_app_number] => 637873 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2988407 [patent_doc_number] => 05212235 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-05-18 [patent_title] => 'Hydrophobically modified proteins' [patent_app_type] => 1 [patent_app_number] => 7/634369 [patent_app_country] => US [patent_app_date] => 1990-12-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 17593 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/212/05212235.pdf [firstpage_image] =>[orig_patent_app_number] => 634369 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2831400 [patent_doc_number] => 05098977 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-03-24 [patent_title] => 'Methods and compositions for providing articles having improved biocompatability characteristics' [patent_app_type] => 1 [patent_app_number] => 7/632920 [patent_app_country] => US [patent_app_date] => 1990-12-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 8477 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/098/05098977.pdf [firstpage_image] =>[orig_patent_app_number] => 632920 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2976646 [patent_doc_number] => 05182365 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1993-01-26 [patent_title] => 'Osteogenic proteins' [patent_app_type] => 1 [patent_app_number] => 7/621988 [patent_app_country] => US [patent_app_date] => 1990-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 30 [patent_figures_cnt] => 41 [patent_no_of_words] => 17559 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/182/05182365.pdf [firstpage_image] =>[orig_patent_app_number] => 621988 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2801574 [patent_doc_number] => 05140086 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-08-18 [patent_title] => 'Isocyanate modified cellulose products and method for their manufacture' [patent_app_type] => 1 [patent_app_number] => 7/618723 [patent_app_country] => US [patent_app_date] => 1990-11-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 16 [patent_no_of_words] => 7980 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 118 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/140/05140086.pdf [firstpage_image] =>[orig_patent_app_number] => 618723 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2863413 [patent_doc_number] => 05162114 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-11-10 [patent_title] => 'Bone collagen matrix for xenogenic implants' [patent_app_type] => 1 [patent_app_number] => 7/616374 [patent_app_country] => US [patent_app_date] => 1990-11-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 13 [patent_no_of_words] => 5882 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/162/05162114.pdf [firstpage_image] =>[orig_patent_app_number] => 616374 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2785538 [patent_doc_number] => 05155096 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-10-13 [patent_title] => 'Method for potentiation of a therapeutic agent' [patent_app_type] => 1 [patent_app_number] => 7/615621 [patent_app_country] => US [patent_app_date] => 1990-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7774 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/155/05155096.pdf [firstpage_image] =>[orig_patent_app_number] => 615621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2876562 [patent_doc_number] => 05118676 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-06-02 [patent_title] => 'Penetration enhancers for transdermal delivery of systemic agents' [patent_app_type] => 1 [patent_app_number] => 7/611600 [patent_app_country] => US [patent_app_date] => 1990-11-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3972 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 87 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/118/05118676.pdf [firstpage_image] =>[orig_patent_app_number] => 611600 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3045056 [patent_doc_number] => 05334612 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-08-02 [patent_title] => 'Pharmaceutical compositions containing as active substance sulphur-containing carboxylic acids and their use in combating retroviruses' [patent_app_type] => 1 [patent_app_number] => 7/610560 [patent_app_country] => US [patent_app_date] => 1990-11-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 9979 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 30 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/334/05334612.pdf [firstpage_image] =>[orig_patent_app_number] => 610560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3050132 [patent_doc_number] => 05324731 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1994-06-28 [patent_title] => 'Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated' [patent_app_type] => 1 [patent_app_number] => 7/610418 [patent_app_country] => US [patent_app_date] => 1990-11-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 40 [patent_no_of_words] => 21981 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 28 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/324/05324731.pdf [firstpage_image] =>[orig_patent_app_number] => 610418 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2823549 [patent_doc_number] => RE033887 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-04-14 [patent_title] => 'Anti-retroviral compounds' [patent_app_type] => 2 [patent_app_number] => 7/608431 [patent_app_country] => US [patent_app_date] => 1990-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6699 [patent_no_of_claims] => 41 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/RE/033/RE033887.pdf [firstpage_image] =>[orig_patent_app_number] => 608431 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2818621 [patent_doc_number] => 05081166 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-01-14 [patent_title] => 'Process for producing a stabilized latex emulsion adhesive' [patent_app_type] => 1 [patent_app_number] => 7/609049 [patent_app_country] => US [patent_app_date] => 1990-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8622 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 199 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/081/05081166.pdf [firstpage_image] =>[orig_patent_app_number] => 609049 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2813595 [patent_doc_number] => 05086076 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-02-04 [patent_title] => 'Antiviral pharmaceutical compositions comprising a terpene ozonide' [patent_app_type] => 1 [patent_app_number] => 7/600316 [patent_app_country] => US [patent_app_date] => 1990-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5965 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/086/05086076.pdf [firstpage_image] =>[orig_patent_app_number] => 600316 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 2852523 [patent_doc_number] => 05126376 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1992-06-30 [patent_title] => 'Method for treating viral infection using topical administration' [patent_app_type] => 1 [patent_app_number] => 7/600604 [patent_app_country] => US [patent_app_date] => 1990-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5991 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/126/05126376.pdf [firstpage_image] =>[orig_patent_app_number] => 600604 [rel_patent_id] =>[rel_patent_doc_number] =>)